In searching for factors that mediate the retinoid anti-cancer signal, we have identified TRIM16 as a DNA binding protein with histone acetyltransferase activity, which is necessary for the retinoic acid receptor β2 transcriptional response in retinoid-treated cancer cells 15, 16. This evidence concerns the gene TRIM16 and cancer.